Form 4: Zimmer Biomet Director's Stock Transactions

Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Summary

• Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc. (ZBH), reported transactions on May 22, 2026.
• These transactions involved phantom stock units and restricted stock units.
• The phantom stock units were accrued under the company's Deferred Compensation Plan for Non-Employee Directors.
• The restricted stock units were immediately 100% vested but subject to mandatory deferral.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions and does not indicate significant positive or negative developments for the company.

Positives

• Director Maria Teresa Hilado's holdings of phantom stock units and restricted stock units remain significant, indicating continued commitment.
• The restricted stock units are immediately vested, providing a clear benefit to the reporting person.

Risks

• The restricted stock units are subject to mandatory deferral until termination of service as a Director or three years after the grant date, which could impact immediate liquidity.
• The value of phantom stock units is tied to the company's common stock price, exposing the reporting person to market volatility.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions and current beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors seeking to understand insider sentiment and potential stock movements.

Stakeholder Impact

• Shareholders: Increased transparency into director's holdings and transactions, which can inform investment decisions.
• Management: Reinforces compliance with SEC reporting requirements.
• Employees: Indirect impact through company's adherence to regulatory standards.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Form 4, Insider Trading, Director, Stock Options, Restricted Stock Units, Phantom Stock Units, Beneficial Ownership, SEC Filing